Chester County News and Community Website
MALVERN, PA — Endo, a wholly-owned subsidiary of Mallinckrodt plc, has introduced the first and only FDA-approved generic version of Amgen’s RAVICTI® (glycerol phenylbutyrate) oral liquid in the United States, …
Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients Read More MALVERN, PA — Endo, a subsidiary of Mallinckrodt plc, has expanded its ADRENALIN® line with the launch of three new FDA-approved premixed intravenous (IV) bag concentrations: 2 mg/250 mL, 5 …
Endo Expands ADRENALIN® Portfolio With New FDA-Approved Premixed IV Bags Read More MALVERN, PA — Endo is presenting new clinical data on collagenase clostridium histolyticum (CCH) as a potential nonsurgical treatment for plantar fibromatosis (PFI) and plantar fasciitis (PFA) during the American …
Endo Highlights New Data on Potential Treatments for Painful Foot Disorders at Orthopaedic Conference Read More MALVERN, PA — Endo, a wholly-owned subsidiary of Mallinckrodt plc, has announced the launch of National Hand Health Month, taking place throughout September. The initiative is intended to raise awareness …
Endo Launches National Hand Health Month to Spotlight Dupuytren’s Contracture Awareness Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) announced it has completed the sale of its International Pharmaceuticals business, primarily operated through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc.
Endo, Inc. Finalizes $105M Sale of International Pharmaceuticals Business Read More DUBLIN, Ireland & MALVERN, PA — Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) announced today that shareholders of both companies have approved the proposed merger, setting the stage for the …
Mallinckrodt and Endo Shareholders Approve Merger Read More DUBLIN, Ireland & MALVERN, PA — Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have detailed the senior leadership structure for their anticipated merger, a move aimed at creating a global …
Mallinckrodt and Endo Announce Leadership Plans for Transformative Merger Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has announced its Men’s Health Month initiative, reaffirming the company’s focus on improving awareness and resources for men’s health issues. Throughout June, the …
Endo, Inc. Launches Men’s Health Month Initiative to Raise Awareness Read More DUBLIN, Ireland & MALVERN, PA — Mallinckrodt plc and Endo, Inc. (OTCQX: NDOI) have announced significant steps forward in their proposed merger aimed at creating a global leader in specialty …
Mallinckrodt and Endo Advance Key Milestones in Strategic Merger Read More MALVERN, PA — Endo, Inc. (OTCQX: NDOI) announced its financial results for the first quarter ended March 31, 2025, highlighting solid growth in the Branded Pharmaceuticals segment and the reaffirmation …
Endo, Inc. Reports First-Quarter 2025 Financial Results Read More